Home > NRC Library > ADAMS Public Documents

621132 New License for Point Biopharma U.S. Inc. to License No. 13-35593-01

Accession Number: ML21070A179

Date Released: Thursday, March 18, 2021

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML21070A174 - 621132 Request for resubmitting the new application for Point Biopharma U.S. Inc. to License No. 13-35593-01 (3 page(s), 7/23/2020)
• ML21070A171 - 621132 Request clarification for the new application for Point Biopharma U.S. Inc. to License No. 13-35593-01 (2 page(s), 7/17/2020)
• ML21070A170 - 621132 RAI dated December 23, 2020 for Point Biopharma U.S. Inc. to License No. 13-35593-01 (2 page(s), 12/23/2020)
• ML21070A169 - 621132 RAI dated February 26, 2021 for Point Biopharma U.S. Inc. to License No. 13-35593-01 (1 page(s), 2/26/2021)
• ML21070A003 - 621132 Cover Letter for POINT Biopharma U.S. Inc. to License No. 13-35593-01 (3 page(s), 3/10/2021)
• ML21070A004 - 621132 New License for POINT Biopharma U.S. Inc. to License No. 13-35593-01 (6 page(s), 3/10/2021)